Skip to main content
. 2022 Oct 11;13:966167. doi: 10.3389/fimmu.2022.966167

Figure 5.

Figure 5

The difference of chemo drugs sensitivity between subtypes, including metformin (A), sorafenib (B), sunitinib (C), methotrexate (D), AKT.inhibitor.VIII (E), bleomycin (F), axitinib (G), AZD8055 (H), etoposide (I), lapatinib (J), cisplatin (K), erlotinib (L).